Skip to content
The Nexus
DossierENTITY

Josh Walkos

Coverage of Josh Walkos in the Nexus archive.

Earliest in view: May 8 · 14:39 UTCMost recent: May 8 · 14:39 UTC
Co-mentioned in this coverage
Marjorie Taylor Greeneperson1Mary Talley Bowdenperson1Ivermectintopic1Andes hantavirustopic1Food and Drug Administration (FDA)organization1Johns Hopkins Center for Health Securityorganization1
Recent coverage
  • HEALTHMay 8 · 14:39 UTCTHE INTERCEPT
    Amid Hantavirus Panic, the Ivermectin Super Fans Are Back

    Prominent Covid-era ivermectin advocates are promoting the drug as a potential treatment for hantavirus despite lack of clinical evidence. The Andes hantavirus outbreak has sparked concerns and misinformation about ivermectin's effectiveness. Health experts emphasize that there is no meaningful clinical evidence supporting ivermectin's use against hantaviruses.

Josh Walkos · Dossier · The Nexus